Skip to main content
NCBI home page
Journal of Medical Ethics logoLink to Journal of Medical Ethics
. 1998 Dec;24(6):401–408. doi: 10.1136/jme.24.6.401

Can unequal be more fair? Ethics, subject allocation, and randomised clinical trials.

A L Avins 1
PMCID: PMC479141  PMID: 9873981

Abstract

Randomised clinical trials provide the most valid means of establishing the efficacy of clinical therapeutics. Ethical standards dictate that patients and clinicians should not consent to randomisation unless there is uncertainty about whether any of the treatment options is superior to the others ("equipoise"). However, true equipoise is rarely present; most randomised trials, therefore, present challenging ethical dilemmas. Minimising the tension between science and ethics is an obligation of investigators and clinicians. This article briefly reviews several techniques for addressing this issue and suggests that unbalanced randomisation, a technique rarely employed in current clinical trial practice, may be useful for enhancing the ethical design of human experimentation.

Full text

PDF
401

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angell M. Patients' preferences in randomized clinical trials. N Engl J Med. 1984 May 24;310(21):1385–1387. doi: 10.1056/NEJM198405243102111. [DOI] [PubMed] [Google Scholar]
  2. Baum M. New approach for recruitment into randomised controlled trials. Lancet. 1993 Mar 27;341(8848):812–813. doi: 10.1016/0140-6736(93)90573-y. [DOI] [PubMed] [Google Scholar]
  3. Berry D. A. A case for Bayesianism in clinical trials. Stat Med. 1993 Aug;12(15-16):1377–1404. doi: 10.1002/sim.4780121504. [DOI] [PubMed] [Google Scholar]
  4. Cairo M. S., Worcester C. C., Rucker R. W., Hanten S., Amlie R. N., Sender L., Hicks D. A. Randomized trial of granulocyte transfusions versus intravenous immune globulin therapy for neonatal neutropenia and sepsis. J Pediatr. 1992 Feb;120(2 Pt 1):281–285. doi: 10.1016/s0022-3476(05)80445-7. [DOI] [PubMed] [Google Scholar]
  5. Casley-Smith J. R., Wang C. T., Casley-Smith J. R., Zi-hai C. Treatment of filarial lymphoedema and elephantiasis with 5,6-benzo-alpha-pyrone (coumarin). BMJ. 1993 Oct 23;307(6911):1037–1041. doi: 10.1136/bmj.307.6911.1037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Echt D. S., Liebson P. R., Mitchell L. B., Peters R. W., Obias-Manno D., Barker A. H., Arensberg D., Baker A., Friedman L., Greene H. L. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21;324(12):781–788. doi: 10.1056/NEJM199103213241201. [DOI] [PubMed] [Google Scholar]
  7. Feinstein A. R. Clinical biostatistics. LI. Quantitative significance and statistical indexes for a contrast of two groups. Clin Pharmacol Ther. 1980 Apr;27(4):567–578. doi: 10.1038/clpt.1980.81. [DOI] [PubMed] [Google Scholar]
  8. Fink A., Kosecoff J., Chassin M., Brook R. H. Consensus methods: characteristics and guidelines for use. Am J Public Health. 1984 Sep;74(9):979–983. doi: 10.2105/ajph.74.9.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fischl M. A., Stanley K., Collier A. C., Arduino J. M., Stein D. S., Feinberg J. E., Allan J. D., Goldsmith J. C., Powderly W. G. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group. Ann Intern Med. 1995 Jan 1;122(1):24–32. doi: 10.7326/0003-4819-122-1-199501010-00004. [DOI] [PubMed] [Google Scholar]
  10. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987 Jul 16;317(3):141–145. doi: 10.1056/NEJM198707163170304. [DOI] [PubMed] [Google Scholar]
  11. Gallo C., Perrone F., De Placido S., Giusti C. Informed versus randomised consent to clinical trials. Lancet. 1995 Oct 21;346(8982):1060–1064. doi: 10.1016/s0140-6736(95)91741-1. [DOI] [PubMed] [Google Scholar]
  12. Goodfield M. J., Andrew L., Evans E. G. Short term treatment of dermatophyte onychomycosis with terbinafine. BMJ. 1992 May 2;304(6835):1151–1154. doi: 10.1136/bmj.304.6835.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gottlieb M. S., Zackin R. A., Fiala M., Henry D. H., Marcel A. J., Combs K. L., Vieira J., Liebman H. A., Cone L. A., Hillman K. S. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. A multicenter, double-blind, placebo-controlled trial. Ann Intern Med. 1991 Jul 15;115(2):84–91. doi: 10.7326/0003-4819-115-2-84. [DOI] [PubMed] [Google Scholar]
  14. High D. M. Advancing research with Alzheimer disease subjects: investigators' perceptions and ethical issues. Alzheimer Dis Assoc Disord. 1993 Fall;7(3):165–178. doi: 10.1097/00002093-199307030-00005. [DOI] [PubMed] [Google Scholar]
  15. High D. M., Whitehouse P. J., Post S. G., Berg L. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper. National Institute on Aging. Alzheimer Dis Assoc Disord. 1994;8 (Suppl 4):66–74. [PubMed] [Google Scholar]
  16. Kopelman L. Randomized clinical trials, consent and the therapeutic relationship. Clin Res. 1983 Feb;31(1):1–11. [PubMed] [Google Scholar]
  17. Korn E. L., Baumrind S. Randomised clinical trials with clinician-preferred treatment. Lancet. 1991 Jan 19;337(8734):149–152. doi: 10.1016/0140-6736(91)90809-4. [DOI] [PubMed] [Google Scholar]
  18. Lau J., Antman E. M., Jimenez-Silva J., Kupelnick B., Mosteller F., Chalmers T. C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992 Jul 23;327(4):248–254. doi: 10.1056/NEJM199207233270406. [DOI] [PubMed] [Google Scholar]
  19. Lavori P. W., Louis T. A., Bailar J. C., 3rd, Polansky M. Designs for experiments--parallel comparisons of treatment. N Engl J Med. 1983 Nov 24;309(21):1291–1299. doi: 10.1056/NEJM198311243092105. [DOI] [PubMed] [Google Scholar]
  20. Mackillop W. J., Palmer M. J., O'Sullivan B., Ward G. K., Steele R., Dotsikas G. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment. Br J Cancer. 1989 Mar;59(3):388–395. doi: 10.1038/bjc.1989.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Marquis D. Leaving therapy to chance. Hastings Cent Rep. 1983 Aug;13(4):40–47. [PubMed] [Google Scholar]
  22. Naylor C. D., Llewellyn-Thomas H. A. Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials? J Clin Epidemiol. 1994 Jul;47(7):787–795. doi: 10.1016/0895-4356(94)90176-7. [DOI] [PubMed] [Google Scholar]
  23. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pocock S. J. Allocation of patients to treatment in clinical trials. Biometrics. 1979 Mar;35(1):183–197. [PubMed] [Google Scholar]
  25. Schafer A. The ethics of the randomized clinical trial. N Engl J Med. 1982 Sep 16;307(12):719–724. doi: 10.1056/NEJM198209163071204. [DOI] [PubMed] [Google Scholar]
  26. Taylor K. M., Margolese R. G., Soskolne C. L. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer. N Engl J Med. 1984 May 24;310(21):1363–1367. doi: 10.1056/NEJM198405243102106. [DOI] [PubMed] [Google Scholar]
  27. Weinstein M. C. Allocation of subjects in medical experiments. N Engl J Med. 1974 Dec 12;291(24):1278–1285. doi: 10.1056/NEJM197412122912405. [DOI] [PubMed] [Google Scholar]
  28. Wiesner R. H., Ludwig J., Lindor K. D., Jorgensen R. A., Baldus W. P., Homburger H. A., Dickson E. R. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med. 1990 May 17;322(20):1419–1424. doi: 10.1056/NEJM199005173222003. [DOI] [PubMed] [Google Scholar]
  29. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979 May 31;300(22):1242–1245. doi: 10.1056/NEJM197905313002203. [DOI] [PubMed] [Google Scholar]
  30. Zelen M. Randomized consent designs for clinical trials: an update. Stat Med. 1990 Jun;9(6):645–656. doi: 10.1002/sim.4780090611. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Ethics are provided here courtesy of BMJ Publishing Group

RESOURCES